Cyclooxygenase inhibitors affect bone mineralization in rat fetuses

Cells Tissues Organs

Volumn 187, Issue 3, 2008, Pages 221-232

  Burdan, Franciszek ^a   Rozylo Kalinowska, Ingrid ^a   Szumilo, Justyna ^a   Dudka, Jaroslaw ^a   Klepacz, Robert ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Bone mineralization; Nonsteroidal anti inflammatory drug; NSAID; Toxicity, developmental

Indexed keywords

5,5 DIMETHYL 3 (3-FLUOROPHENYL) 4 (4 METHYLSULFONYL) PHENYL 2 (5H) FURANONE; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; PIROXICAM; TOLMETIN; UNCLASSIFIED DRUG;

ABSORPTIOMETRY; ARTICLE; BONE MINERALIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FETUS; GROWTH RETARDATION; HEALTH STATUS; LUMBAR VERTEBRA; MATERNAL WELFARE; NONHUMAN; OPTICAL DENSITY; PRENATAL GROWTH; PRIORITY JOURNAL; RAT; TERATOGENICITY; X RAY;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LUMBAR VERTEBRAE; MALE; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; ORGAN SIZE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR;

RATTUS;

EID: 40849104868     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111077     Document Type: Article

References (57)

1. Adams, S.S., R.G. Bough, E.E. Cliffe, B. Lessel, R.F. Mills (1969) Absorption, distribution and toxicity of ibuprofen. Toxicol Appl Pharmacol 15: 310-330.
2. Aliverti, V., L. Bonanomi, E. Giavini, V.G. Leone, L. Mariani (1979) The extent of fetal ossification as an index of delayed development in teratogenic studies on the rat. Teratology 20: 237-242.
3. Bauer, D.C., E.S. Orwoll, K.M. Fox, T.M. Vogt, N.E. Lane, M.C. Hochberg, K. Stone, M.C. Nevitt (1996) Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. J Bone Miner Res 11: 29-35.
4. Beck, S.L. (1990) Prenatal and postnatal assessment of maneb-exposed CD-1 mice. Reprod Toxicol 4: 283-290.
5. Boluk, A., M. Guzelipek, H. Savli, I. Temel, H.I. Ozisik, A. Kaygusuz (2004) The effect of valproate on bone mineral density in adult epileptic patients. Pharmacol Res 50: 93-97.
6. Briggs, G.G., R. Freeman, S.J. Yaffe (1998) Drugs in Pregnancy and Lactation: a Reference Guide to Fetal and Neonatal Risk, ed 5. Baltimore, Williams & Wilkins.
7. Burdan, F. (2004) Developmental toxicity evaluation of ibuprofen and tolmetin administered in triple daily doses to Wistar CRL:(WI)WUBR rats. Birth Defects Res B Dev Reprod Toxicol 69: 321-330.
8. Burdan, F. (2005) Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in rats - DFU and piroxicam study. Toxicology 211: 12-25.
9. Burdan, F., J. Dudka, J. Szumilo, A. Korobowicz, L. Klepacz (2003) Prenatal effect of DuP-697 - the irreversible, highly selective cyclooxygenase-2 inhibitor. Reprod Toxicol 17: 413-419.
10. Burdan, F., I. Rozylo-Kalinowska, T.K. Rozylo, I. Chahoud (2002) A new, rapid radiological procedure for routine teratological use in bone ossification assessment: a supplement for staining methods. Teratology 66: 315-325.
11. Burdan, F., J. Szumilo, J. Dudka, R. Klepacz, M. Blaszczak, M. Solecki, A. Korobowicz, A. Chalas, J. Klepacki, M. Palczak, A. Hadala-Kis, Z. Urbanowicz, Z. Wojtowicz (2005a) Morphological studies in modern teratological investigations. Folia Morphol 64: 1-8.
12. Burdan, F., J. Szumilo, J. Dudka, A. Korobowicz, R. Klepacz (2006) Celosomy is associated with prenatal exposure to cyclooxygenase inhibitors. Pharmacol Res 53: 287-292.
13. Burdan, F., J. Szumilo, R. Klepacz, J. Dudka, A. Korobowicz, E. Tokarska, M. Cendrowska-Pinkosz, B. Madej, L. Klepacz (2004) Gastrointestinal and hepatic toxicity of selective and nonselective cyclooxygenase-2 inhibitors in pregnant and nonpregnant rats. Pharmacol Res 50: 534-544.
14. Burdan, F., J. Szumilo, B. Marzec, R. Klepacz, J. Dudka (2005b) Skeletal developmental effects of selective and nonselective cyclooxygenase-2 inhibitors administered through organogenesis and fetogenesis in Wistar CRL:(WI)WUBR rats. Toxicology 216: 204-223.
15. Cappon, G.D., T.L. Fleeman, J.C. Cook, M.E. Hurtt (2005) Combined treatment potentiates the developmental toxicity of ibuprofen and acetazolamide in rats. Drug Chem Toxicol 28: 409-421.
16. Chahoud, I., F.J.R. Paumgartten (2005) Relationship between fetal body weight of Wistar rats at term and the extent of skeletal ossification. Braz J Med Biol Res 38: 565-575.
17. Chernoff, N., J.M. Rogers, C.I. Turner, B.M. Francis (1991) Significance of supernumerary ribs in rodent developmental toxicity studies: postnatal persistence in rats and mice. Fundam Appl Toxicol 17: 448-453.
18. Christian, M.S. (2001) Test methods for assessing female reproductive and developmental toxicology; in Hayes, A.W. (ed): Principles and Method of Toxicology, ed 4. Philadelphia, Taylor & Francis, pp 1301-1381.
19. Cook, J.C, C.F. Jacobson, F. Gao, M.S. Tassinari, M.E. Hurtt, J.M. DeSesso (2003) Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits. Birth Defects Res B Dev Reprod Toxicol 68: 5-26.
20. Czyz, M., A. Kedzia (2003) Preliminary metrological study of the lumbar vertebral column during the fetal period. Folia Morphol 62: 259-262.
21. Dannhardt, G., W. Kiefer (2001) Cyclooxygenase inhibitors - current status and future prospects. Eur J Med Chem 36: 109-126.
22. DevTox: 2006 classification of rat developmental abnormality. http//www.DevTox.org (accessed December 14, 2006).
23. Dogne, J.M., C.T. Supuran, D. Pratico (2005) Adverse cardiovascular effects of the coxibs. J Med Chem 48: 2251-2257.
24. Engelbregt, M.J., M.M. van Weissenbruch, P. Lips, A. van Lingen, J.C. Roos, H.A. Delemarre-van de Waal (2004) Body composition and bone measurements in intra-uterine growth retarded and early postnatally undernourished male and female rats at the age of 6 months: comparison with puberty. Bone 34: 180-186.
25. Faqui, A., K. Collisin, J.P. Shea, R. Schroeder (2006) Fetal skeletal evaluation: CT-scan versus alizarin red. Birth Defects Res A Clin Mol Teratol 76: 401.
26. Genant, H.K., Y. Jiang (2006) Advanced imaging assessment of bone quality. Ann NY Acad Sci 1068: 410-428.
27. Golovanova, I.V., A.M. Skosyreva, S.A. Sharova, T.A. Guskova (1985) Tolerance of some nonsteroidal anti-inflammatory drugs by experimental animals in pregnancy. Farmakol Toksikol 48: 66-69.
28. Guldberg, R.E., A.S.P. Lin, R. Coleman, G. Robertson, C. Duvall (2004) Microcomputed tomography imaging of skeletal development and growth. Birth Defects Res B Dev Reprod Toxicol 72: 250-259.
29. Gupta, I., K.J. Thmas, H. Datta, V.S. Mathur (1984) Effect of ibuprofen and naproxen on implantation and pregnancy in rat. Indian J Exp Biol 22: 282-283.
30. Johnson, D.C., S. Chatterjee (1995) The role of arachidonic acid and/or its metabolites in embryo implantation inhibited by epidermal growth factor (EGF). Prostaglandins Leukot Essent Fatty Acids 52: 29-35
31. Kawaguchi, H., C.C. Pilbeam, J.R. Harrison, L. G. Raisz (1995) The role of prostaglandin in the regulation of bone metabolism. Clin Orthop Res 313: 36-46.
32. Krinke, G.J. (2000) The Laboratory Rat. London, Academic Press.
33. Lane, N., T. Coble, D.B. Kimmel (1990) Effect of naproxen on cancellous bone in ovariectomized rats. J Bone Miner Res 5: 1029-1035.
34. Lee, T.C., S. Mohsin, D. Taylor, R. Perkesh, T. Gunnlaugsson, F.J.O. O'Brien, M. Giehl, W. Gowin (2003) Detecting microdamage in bone. J Anat 203: 161-172.
35. Manson, J.M., Y.J. Kang (1994) Test methods for assessing female reproductive and developmental toxicology; in Hayes, A. (ed): Principles and Methods of Toxicology, ed 3. New York, Raven Press, pp 989-1037.
36. Morton, D.J., E.L. Barrett-Connor, D.L. Schneider (1998) Nonsteroidal anti-inflammatory drugs and bone mineral density in older women: the Rancho Bernardo Study. J Bone Miner Res 13: 1924-1931.
37. Nishimura, K., S. Fukagawa, K. Shigematsu (1977) Teratogenicity study of 1-methyl-5-p-toluoylpyrrole-2-acetate sodium dihydrate (tolmentin sodium) in rabbits. Iyakuhin Kenkyu 8: 158-164.
38. Ohta, M., G. Cheuk, K.A. Thomas, Y. Kamagata-Kiyoura, C.S. Wink, M. Yazdani, A.U. Falster, W.B. Simmons, T. Nakamoto (1999) Effects of caffeine on bones of aged, ovariectomized rats. Ann Nutr Metab 43: 52-59.
39. Okada, A., H. Kurihara, Y. Aoki, M. Bialer, M. Fujiwara (2004) Amidic modification of valproic acid reduces skeletal teratogenicity in mice. Birth Defects Res B Dev Reprod Toxicol 71: 47-53.
40. Ono, M., F. Hoshida, M. Nagase, K. Asami (1982a) Reproductive studies of ibuprofen by rectal administration. 2. Teratogenicity study in rats. Oyo Yakuri 24: 531-538.
41. Ono, M., Y. Ogawa, K. Ogihara, M. Nagase, K. Asami (1982b) Reproduction studies of ibuprofen by rectal administration. 1. Fertility study in rats. Oyo Yakuri 24: 467-473.
42. Ostensen, M., J.F. Skomsvoll (2004) Anti-inflammatory pharmacotherapy during pregnancy. Expert Opin Pharmacother 5: 571-580.
43. PDR (1998) Physicians' Desk Reference, ed 52. Montvale, Medical Economics, pp 1536-1545, 2056-2058, 2179-2181.
44. PDR (2003) PDR Electronic Library. Release 2003.1AX. Thomson PDR, CD-ROM. Perraud, J., J. Stadler, M.J. Kessedjian, A.M. Monro (1984) Reproductive studies with the anti-inflammatory agent, piroxicam: modification of classical protocols. Toxicology 30: 59-63.
45. Peskar, B.M., K. Ehrlich, B.A. Peskar (2002) Interaction of cyclooxygenase-2 inhibitors and salicylate in gastric mucosal damage. Eur J Pharmacol 434: 65-70.
46. Powell, J.G., Jr., R.L. Czochrane (1982) The effects of a number of non-steroidal anti-inflammatory compounds on parturition in the rat. Prostaglandins 23: 469-488.
47. Pruszynski, B. (2004) Radiology. Warsaw, PZWL.
48. Reid, I.R. (2002) Relationship among body mass, its components and bone. Bone 31: 547-555.
49. Rozylo-Kalinowska, I., A. Michalska, F. Burdan (2003) Optimisation of analysis of skeletal ossification of laboratory animals by means of digital radiography software options. Ann Univ Mariae Curie Sklodowska Med 58: 95-100.
50. Sakai, T., I. Ohtsuki, F. Noguchi (1980) Effects of piroxicam on fertility. Yakuri to Chiryo 8: 4655-4671.
51. Skawina, A., J.A. Litwin, J. Gorczyca, A.J. Miodonski (1997) The architecture of internal blood vessels in human fetal vertebral bodies. J Anat 191: 259-267.
52. Tothill, P., W.J. Hannan (2002) Bone mineral and soft tissue measurements by dual-energy X-ray absorptiometry during growth. Bone 31: 492-496.
53. Wu, Y., D.A. Chesler, M.J. Glimcher, L. Garrido, J. Wang, H.J. Jiang, J.L. Ackerman (1999) Multinuclear solid-state three-dimensional MRI of bone and synthetic calcium phosphates. Proc Natl Acad Sci USA 16: 1574-1578.
54. Young, A.D., D.E. Phipps, A.B. Astroff (2000) Large-scale double-staining of rat fetal skeletons using alizarin red S and alcian blue. Teratology 61: 273-276.
55. Zhang, X., S.G. Morham, R. Longenbach, D.A. Young, L. Xing, B.F. Boyce, E.J. Puzas, R.N. Rosier, R.J. O'Keefe, E.M. Schwarz (2001) Evidence for direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis. J Bone Miner Res 16: 660-670.
56. Zoetis, T., M.S. Tassinari, C. Bagi, K. Walthall, M.E. Hurtt (2003) Species comparison of postnatal bone growth and development. Birth Defects Res B Dev Reprod Toxicol 68: 86-110.
57. Zuhlke, U., S. Mohr (2000) Future trends in primate toxicology and refined techniques; in Korte, R., G.F. Weinbauer (eds): Towards New Horizons in Primate Toxicology. Münster, Wamann, pp 233-242.